It operates by mimicking the functions of the human glucagon-like peptide-1 (GLP-1), thereby enhancing insulin secretion, inhibiting glucagon release, and ultimately leading to improved glycemic control and weight loss
More recently, an oral versionRybelsushas entered the market, offering a needle-free alternative
Methods This retrospective real-world study evaluated 106 adults aged 1875 years with newly diagnosed T2D who initiated semaglutide (1.0 mg) or dulaglutide (1.5 mg) between December 2023 and December 2024
While these medications are beneficial for many patients, they are not for everyone, and serious side effects are possible, especially in those with a history of pancreatitis, gallbladder issues, or thyroid tumors
Support for regenerative wellness applications
Book a Consultation How It Works KPV targets multiple inflammatory pathways to support gut health and immune balance